M M Joffe1. 1. Division of Biostatistics, Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 602 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA.
Abstract
PURPOSE: To review conceptual issues regarding confounding by indication in the context of studies of calcium channel blockers (CCBs). METHODS: Review of literature, with special attention to two articles in the current issue. RESULTS: Conflicting arguments about the presence of uncontrollable confounding by indication in studies of CCBs are reviewed and criticized. Studies with potential confounding by indication can benefit from appropriate analytic methods, including separating the effects of a drug taken at different times, sensitivity analysis for unmeasured confounders, and instrumental variables and G-estimation. CONCLUSIONS: Whether confounding by indication accounts for observed associations is often difficult to determine; this is the case in studies of CCBs. When confounding by indication is suspected, a variety of methods to deal with it may be useful. Copyright (c) 2000 John Wiley & Sons, Ltd.
PURPOSE: To review conceptual issues regarding confounding by indication in the context of studies of calcium channel blockers (CCBs). METHODS: Review of literature, with special attention to two articles in the current issue. RESULTS: Conflicting arguments about the presence of uncontrollable confounding by indication in studies of CCBs are reviewed and criticized. Studies with potential confounding by indication can benefit from appropriate analytic methods, including separating the effects of a drug taken at different times, sensitivity analysis for unmeasured confounders, and instrumental variables and G-estimation. CONCLUSIONS: Whether confounding by indication accounts for observed associations is often difficult to determine; this is the case in studies of CCBs. When confounding by indication is suspected, a variety of methods to deal with it may be useful. Copyright (c) 2000 John Wiley & Sons, Ltd.
Authors: Adam D Gepner; Yacob Tedla; Laura A Colangelo; Matthew C Tattersall; Claudia E Korcarz; Joel D Kaufman; Kiang Liu; Gregory L Burke; Steven Shea; Philip Greenland; James H Stein Journal: Hypertension Date: 2016-11-14 Impact factor: 10.190
Authors: Johan S de Koning; Niek S Klazinga; Peter J Koudstaal; Ad Prins; Gerard J J M Borsboom; Johan P Mackenbach Journal: BMC Health Serv Res Date: 2005-01-27 Impact factor: 2.655
Authors: Blánaid M Hicks; John Busby; Ken Mills; Francis A O'Neil; Stuart A McIntosh; Shu-Dong Zhang; Fabio Giuseppe Liberante; Chris R Cardwell Journal: BMC Cancer Date: 2020-08-24 Impact factor: 4.430
Authors: Simon Jc Davies; David Rudoler; Claire de Oliveira; Anjie Huang; Paul Kurdyak; Andrea Iaboni Journal: J Psychopharmacol Date: 2022-02-01 Impact factor: 4.562